Esophageal Cancer Mesothelioma Web Directory, and Resources |
||||||||||||||||||||||||
Esophageal Cancer Mesothelioma Resources
This site contains resources and articles for you to use when you are looking for information about esophageal cancer mesothelioma. This site has articles, links to esophageal cancer mesothelioma, information and news. In the future we will have reviews of products that will help you make your decision easier with esophageal cancer mesothelioma, so you can save time
Featured Esophageal Cancer Mesothelioma Article
Mesothelioma Treatment Overview By: Standard treatment for all but localized mesothelio ma is generally not curative. Although some patients will experience long-term survival with aggressive treatme nt approaches, it remains unclear if overall survival has been significantly altered by the different treatment modalities or by combinations of modalities. Extrapleur al pneumonectomy in selected patients with early stage disease may improve recurrence-free survival, but its impact on overall survival is unknown. Pleurectomy and decortication can provide palliative relief from symptomatic effusions, discomfort caused by tumor burden, and pain caused by invasive tumor. Operative mortality from pleurectomy/decortication is less than 2%, while mortality from extrapleural pneumonectomy has ranged from 6% to 30%. The addition of radiation therapy and/or chemotherapy following surgical intervention has not demonstrated improved survival. The use of radiatio n therapy in pleural mesothelioma has been shown to alle viate pain in the majority of patients treated. However, the duration of symptom control is short-lived. Single agent and combination chemotherapy have been evaluated in single and combined modality studies. The most studied agent is doxorubicin, which has produced partial responses in approximately 15% to 20% of patients studied. Some combination chemotherapy regimens have been reported to have higher response rates in small phase II trials. However the toxicity reported is also higher and there is no evidence that combination regimens result in longer survival or longer control of symptoms. Recurrent pleural effusions may be treated with pleural sclerosing procedures; however, failure rates are usually secondary to the bulk of the tumor, which precludes pleural adhesion due to the inability of the lung to fully expand. The designations in PDQ that treatments are ģstandardī or ģunder clinical evaluationī are not to be used as a basis for reimbursement determinations. ....[MORE]
Sponsored Esophageal Cancer Mesothelioma ResourcesThese are our featured resources and providers for esophageal cancer mesothelioma. Feel free to check them out if you are looking for resources and articles for you to use. This list includes sites with articles, esophageal cancer mesothelioma resources, information and news. Additional Esophageal Cancer Mesothelioma Resources
|